Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering.

Key benefits

• In-depth understanding of Molecular Diagnostics deal trends since 2015

• Access to headline, upfront, milestone and royalty data

• Detailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies

• Identify most active Molecular Diagnostics dealmakers since 2015

• Insight into terms included in a Molecular Diagnostics partnering agreement, with real world examples

• Understand the key deal terms companies have agreed in previous deals

• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

This report provides details of the latest Molecular Diagnostics agreements announced in the life sciences since 2015.

The report presents financial deal term values for Molecular Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Molecular Diagnostics partnering field; both the leading deal values and most active Molecular Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 950 online deal records of actual Molecular Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Molecular Diagnostics technologies and products.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Molecular Diagnostics dealmaking
2.1. Introduction
2.2. Molecular Diagnostics partnering over the years
2.3. Most active Molecular Diagnostics dealmakers
2.4. Molecular Diagnostics partnering by deal type
2.5. Molecular Diagnostics partnering by therapy area
2.6. Deal terms for Molecular Diagnostics partnering

Chapter 3 - Leading Molecular Diagnostics deals
3.1. Introduction
3.2. Top Molecular Diagnostics deals by value

Chapter 4 - Most active Molecular Diagnostics dealmakers
4.1. Introduction
4.2. Most active Molecular Diagnostics dealmakers
4.3. Most active Molecular Diagnostics partnering company profiles

Chapter 5 - Molecular Diagnostics contracts dealmaking directory
5.1. Introduction
5.2. Molecular Diagnostics contracts dealmaking directory

Chapter 6 - Molecular Diagnostics dealmaking by technology type

Companies Mentioned

• 2bPrecise

• 2cureX

• 3D BioMed

• 3PrimeDx

• 4D Path

• 10X Genomics

• 14M Genomics

• 23andMe

• 221b Foundation

• A*STAR Agency for Science

• Technology and Research

• Abbott Laboratories

• Abbvie

• Abcam

• Abcodia

• Abramson Cancer Center

• Accelerate Diagnostics

• Accelerate Technologies

• Access BIO

• AccuGenomics

• AccuRef Diagnostics

• AC Immune

• Acumen Pharmaceuticals

• Acupath Laboratories

• Adaptive Biotechnologies

• Adial Pharmaceuticals

• Aditx Therapeutics

• ADMA Biologics

• Admera Health

• ADS

• Advanced Biological Laboratories

• Advanced Cell Diagnostics

• Advanced Cooling Therapy

• Advanced Genomic Solutions

• Advanced Medical German Company of Kuwait

• ADx Healthcare

• Aegea Biotechnologies

• Aetna

• Affymetrix

• Age Labs

• Agena Bioscience

• Agendia

• Agilent Technologies

• Agios Pharmaceuticals

• Air Force Research Laboratory

• Akers Biosciences

• Ako Med

• Akonni Biosystems

• Akoya Biosciences

• Alamar Biosciences

• Albertsons Companies

• ALBOT Technologies

• Aldeyra Therapeutics

• Alibaba Health

• Allele Biotechnology and Pharmaceuticals

• Allelica

• Alliance Global FZ

• Alliance Global Group

• Almac Diagnostics

• Alnylam Pharmaceuticals

• Alpha-Tec Systems

• Alphazyme

• Alverno Clinical Laboratories

• Alzheimer's Drug Discovery Foundation

• Alzheon

• Amazon Web Services

• Ambry Genetics

• A Menarini Diagnostics

• America's Choice Provider Network

• Amgen

• Amoy Diagnostics

• Amplitech

• Anavasi Diagnostics

• AnchorDx

• Angle

• Angsana Molecular & Diagnostics

• Anixa Biosciences

• Annar Health Technologies

• Anpac Bio-Medical Science

• AnteoTech

• Anthem Bluecross

• Antisoma Therapeutics

• Applied BioCode

• Aptorum Group

• Arbor Biosciences

• ArcherDX

• Ares Genetics

• Ares Life Sciences

• Ariosa Diagnostics

• Arisan Therapeutics

• Arizona State University

• AroCell

• Arrow Diagnostics

• Ashion Analytics

• ASPiRA Labs

• Aspira Scientific

• Assistance Publique-Hopitaux de Paris

• Astellas Pharma

• Asterand Bioscience

• Asthma UK

• AstraZeneca

• Astute Medical

• Asuragen

• AsureQuality

• ATGen Global

• Athletigen

• Atlas Antibodies

• Atlas Genetics

• Atlas Genomics

• Atomo Diagnostics

• Atrin Pharmaceuticals

• Atrys Health

• Autobio Diagnostics

• AutoGenomics

• Avacta

• Avalon GloboCare

• Avant Diagnostics

• Avera Health

• Avricore Health

• Axella Research

• AXIM Biotechnologies

• Babson Diagnostics

• Baebies

• BASE10 Genetics

• Bay Area Lyme Foundation

• Bayer

• Baylor Genetics

• BBI Solutions

• BC Neuroimmunology

• BC Platforms

• BD Biosciences

• Beckman Coulter

• Be Creative Lab

• Becton Dickinson

• Beijing Genomics Institute (BGI)

• Berg

• Beroni Group

• Berry Genomics

• Berry Oncology

• Bertech Diagnostics

• Be The Match BioTherapies

• BHR Pharma

• Bill and Melinda Gates Foundation

• BillionToOne

• Bio-Me

• Bio-Rad Laboratories

• Bio-Techne

• bioAffinity Technologies

• BioAnalytical Systems

• BIOASTER

• Biocartis

• Biocept

• BioChain

• BioCheck

• Biodesix

• Biodirection

• BioDiscovery

• Biodist

• Biofidelity

• BioGemex

• Biognosys

• BioGX

• Biohealth Innovation

• Biohit Healthcare

For more information about this report visit https://www.researchandmarkets.com/r/wnbemx

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900